Comparing the current results to its competitors, Lemaitre Vascular Inc reported Revenue increase in the 1 quarter 2026 by 11.74 % year on year. The sales growth was above Lemaitre Vascular Inc 's competitors' average revenue growth of 4.21 %, achieved in the same quarter.
Lemaitre Vascular Inc Net Income in the 1 quarter 2026 grew year on year by 42.39%, faster than the Lemaitre Vascular Inc 's competitors average income growth of 1.84 %
Lemaitre Vascular Inc 's Comment on Competition and Industry Peers
The company operates in segments marked by technological advancements and scientific discoveries. It faces competition from various companies rather than a single competitor across all product lines. Key competitors include Abbott, Baxter, Artivion, Becton Dickinson, Edwards Lifesciences, Getinge, LifeNet Health, Terumo, and W. L. Gore. Many of these competitors possess significantly greater financial, technological, research and development, regulatory, marketing, sales, and personnel resources. Some competitors can produce at lower costs and offer products at lower prices, particularly polyester and ePTFE vascular grafts. Additionally, competitors may have more experience in product development, regulatory approvals, manufacturing, marketing, and sourcing tissue for allografts. Certain competitors may also hold patent protection or regulatory approvals that provide competitive advantages.
Company's competitiveness improved within Overall company, with revenue growth of 11.74 % and its market share increased to approx. 0.18 %. << More on LMAT Market Share.
*Market share is calculated based on total revenue.
Merit Medical Systems Inc operates as a medical device company that develops, manufactures, and distributes disposable medical devices. Their business model focuses on delivering high-quality and innovative products to healthcare professionals and hospitals worldwide. They generate revenue through the sales and distribution of their medical devices, aiming to improve patient outcomes and provide value to healthcare providers.
Meihua International Medical Technologies Co Ltd Share Performance
-41.46%
Over The Past 5 Days
Meihua International Medical Technologies Co Ltd
Profile
Meihua International Medical Technologies Co. Limi operates on a business model focused on the development and distribution of medical technologies and solutions. The company aims to deliver innovative and quality medical equipment to healthcare providers and institutions globally. By leveraging their expertise and partnerships, Meihua strives to enhance healthcare outcomes and contribute to the advancement of medical technology.
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Livanova Plc is a global medical technology company that focuses on developing and delivering innovative solutions for patients with cardiovascular diseases and neuropsychiatric disorders. Through their diverse portfolio, they offer products and therapies that encompass surgical heart valves, cardiac rhythm management, and neuromodulation. Livanova adopts a patient-centric approach, collaborating with healthcare professionals to improve patient outcomes and enhance quality of life.
Sources:
Lemaitre Vascular Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Lemaitre Vascular Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
